Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Shepherd

Showing results (31-40 of 105) with videos related to

Pageof 11
Sort By:
Journal of Environmental Management|October 3, 2021
Mapping bare ground in New Zealand hill-country agriculture and forestry for soil erosion risk assessment: An automated satellite remote-sensing methodHeather North, Alexander Amies, John Dymond, et al.
The American Journal of Cardiology|January 28, 2010
Comparison of 80 versus 10 mg of atorvastatin on occurrence of cardiovascular events after the first event (from the Treating to New Targets [TNT] trial)John C LaRosa, Prakash C Deedwania, James Shepherd, et al.
The American Journal of Cardiology|March 5, 2016
Relation Between Change in Renal Function and Cardiovascular Outcomes in Atorvastatin-Treated Patients (from the Treating to New Targets [TNT] Study)James Shepherd, Andrei Breazna, Prakash C Deedwania, et al.
Heart (British Cardiac Society)|February 18, 2011
Obesity is associated with fatal coronary heart disease independently of traditional risk factors and deprivationJennifer Logue, Heather M Murray, Paul Welsh, et al.
The American Journal of Cardiology|October 7, 2004
Safety of rosuvastatinJames Shepherd, Donald B Hunninghake, Evan A Stein, et al.
European Heart Journal|April 17, 2010
Fasting plasma glucose in non-diabetic participants and the risk for incident cardiovascular events, diabetes, and mortality: results from WOSCOPS 15-year follow-upDavid Preiss, Paul Welsh, Heather M Murray, et al.
Current Medical Research and Opinion|October 7, 2004
Lipid-modifying effects of rosuvastatin in postmenopausal women with hypercholesterolemia who are receiving hormone replacement therapyJames Shepherd, Chris Packard, Thomas W Littlejohn, et al.
Atherosclerosis|July 18, 2002
Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance ratesLorne F Forster, Grace Stewart, Dorothy Bedford, et al.
Environmental Science & Technology|February 12, 2025
Utilizing Internet Search Trends and Wastewater Surveillance to Identify Infectious Disease Outbreaks in CommunitiesAlessandro Zulli, Zoe Zhang, Madelena Ruedaflores, et al.
Circulation|March 27, 2002
Coronary heart disease in patients with low LDL-cholesterol: benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factorsFrank M Sacks, Andrew M Tonkin, Timothy Craven, et al.
Pageof 11

Showing results (31-40 of 105) with videos related to

Sort By:
Pageof 11
Journal of Environmental Management|October 3, 2021
Mapping bare ground in New Zealand hill-country agriculture and forestry for soil erosion risk assessment: An automated satellite remote-sensing methodHeather North, Alexander Amies, John Dymond, et al.
The American Journal of Cardiology|January 28, 2010
Comparison of 80 versus 10 mg of atorvastatin on occurrence of cardiovascular events after the first event (from the Treating to New Targets [TNT] trial)John C LaRosa, Prakash C Deedwania, James Shepherd, et al.
The American Journal of Cardiology|March 5, 2016
Relation Between Change in Renal Function and Cardiovascular Outcomes in Atorvastatin-Treated Patients (from the Treating to New Targets [TNT] Study)James Shepherd, Andrei Breazna, Prakash C Deedwania, et al.
Heart (British Cardiac Society)|February 18, 2011
Obesity is associated with fatal coronary heart disease independently of traditional risk factors and deprivationJennifer Logue, Heather M Murray, Paul Welsh, et al.
The American Journal of Cardiology|October 7, 2004
Safety of rosuvastatinJames Shepherd, Donald B Hunninghake, Evan A Stein, et al.
European Heart Journal|April 17, 2010
Fasting plasma glucose in non-diabetic participants and the risk for incident cardiovascular events, diabetes, and mortality: results from WOSCOPS 15-year follow-upDavid Preiss, Paul Welsh, Heather M Murray, et al.
Current Medical Research and Opinion|October 7, 2004
Lipid-modifying effects of rosuvastatin in postmenopausal women with hypercholesterolemia who are receiving hormone replacement therapyJames Shepherd, Chris Packard, Thomas W Littlejohn, et al.
Atherosclerosis|July 18, 2002
Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance ratesLorne F Forster, Grace Stewart, Dorothy Bedford, et al.
Environmental Science & Technology|February 12, 2025
Utilizing Internet Search Trends and Wastewater Surveillance to Identify Infectious Disease Outbreaks in CommunitiesAlessandro Zulli, Zoe Zhang, Madelena Ruedaflores, et al.
Circulation|March 27, 2002
Coronary heart disease in patients with low LDL-cholesterol: benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factorsFrank M Sacks, Andrew M Tonkin, Timothy Craven, et al.
Pageof 11